by The global veterinary medicine market size accounted for US$ 45.71 Bn in 2022 and is projected to reach around USD 93.67 Bn by 2032, growing at a CAGR of 7.43% from 2023 to 2032.
Report Summary
The global veterinary medicine market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the veterinary medicine market across the globe.
A comprehensive estimate on the veterinary medicine market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of veterinary medicine during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2584
Veterinary Medicine Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 49.11 Billion |
| Market Size by 2032 | USD 93.67 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 7.43% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Animal Type, By Product, By Mode of Delivery and By End-User |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized veterinary medicine market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Artificial Intelligence (AI) Chip Market Size Analysis 2023 To 2032
Veterinary Medicine Market Players
The report includes the profiles of key veterinary medicine market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Major companies operating in this area
- Ceva Sante Animale
- Vetoquinol S.A.
- Zoetis
- Biogenesis Bago
- Neogen Corp.
- Hester Biosciences
- Phibro Animal Health
- Ceva Sante Animale
- Vetoquinol S.A.
- Dechra Pharmaceuticals PLC
Market Segmentation
By Animal Type
- Production
- Poultry
- Swine
- Cattle
- Sheep & Goats
- Fish
- Companion
- Dogs
- Cats
- Horses
- Others
By Product
- Biologics
- Vaccine
- Live Attenuated Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Inactivated Vaccines
- Others
- Others
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Medicated Feed Additives
By Mode of Delivery
- Oral
- Powder
- Tablets
- Parenteral
- Suspension
- Topical
- Carrier
- Other
By End-User
- Reference Laboratories
- Point-of-care Testing/In-house Testing
- Veterinary Hospitals & Clinics
- Others
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Veterinary Medicine Market
5.1. COVID-19 Landscape: Veterinary Medicine Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Veterinary Medicine Market, By Animal Type
8.1. Veterinary Medicine Market, by Animal Type, 2023-2032
8.1.1. Production
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Companion
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Veterinary Medicine Market, By Product
9.1. Veterinary Medicine Market, by Product, 2023-2032
9.1.1. Biologics
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Others
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Pharmaceuticals
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Medicated Feed Additives
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Veterinary Medicine Market, By Mode of Delivery
10.1. Veterinary Medicine Market, by Mode of Delivery, 2023-2032
10.1.1. Oral
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Parenteral
10.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Veterinary Medicine Market, By End-User
11.1. Veterinary Medicine Market, by End-User, 2023-2032
11.1.1. Reference Laboratories
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Point-of-care Testing/In-house Testing
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Veterinary Hospitals & Clinics
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Veterinary Medicine Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.1.2. Market Revenue and Forecast, by Product (2020-2032)
12.1.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.1.4. Market Revenue and Forecast, by End-User (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Product (2020-2032)
12.1.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.1.5.4. Market Revenue and Forecast, by End-User (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Product (2020-2032)
12.1.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.1.6.4. Market Revenue and Forecast, by End-User (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.2.2. Market Revenue and Forecast, by Product (2020-2032)
12.2.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.2.4. Market Revenue and Forecast, by End-User (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Product (2020-2032)
12.2.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.2.5.4. Market Revenue and Forecast, by End-User (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Product (2020-2032)
12.2.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.2.6.4. Market Revenue and Forecast, by End-User (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Product (2020-2032)
12.2.7.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.2.7.4. Market Revenue and Forecast, by End-User (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Product (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.2.8.4. Market Revenue and Forecast, by End-User (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.3.2. Market Revenue and Forecast, by Product (2020-2032)
12.3.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.3.4. Market Revenue and Forecast, by End-User (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Product (2020-2032)
12.3.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.3.5.4. Market Revenue and Forecast, by End-User (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Product (2020-2032)
12.3.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.3.6.4. Market Revenue and Forecast, by End-User (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Product (2020-2032)
12.3.7.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.3.7.4. Market Revenue and Forecast, by End-User (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Product (2020-2032)
12.3.8.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.3.8.4. Market Revenue and Forecast, by End-User (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.4.2. Market Revenue and Forecast, by Product (2020-2032)
12.4.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.4.4. Market Revenue and Forecast, by End-User (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Product (2020-2032)
12.4.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.4.5.4. Market Revenue and Forecast, by End-User (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Product (2020-2032)
12.4.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.4.6.4. Market Revenue and Forecast, by End-User (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Product (2020-2032)
12.4.7.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.4.7.4. Market Revenue and Forecast, by End-User (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Product (2020-2032)
12.4.8.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.4.8.4. Market Revenue and Forecast, by End-User (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.5.2. Market Revenue and Forecast, by Product (2020-2032)
12.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.5.4. Market Revenue and Forecast, by End-User (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Product (2020-2032)
12.5.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.5.5.4. Market Revenue and Forecast, by End-User (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Animal Type (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Product (2020-2032)
12.5.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)
12.5.6.4. Market Revenue and Forecast, by End-User (2020-2032)
Chapter 13. Company Profiles
13.1. Ceva Sante Animale
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Vetoquinol S.A.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Zoetis
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Biogenesis Bago
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Neogen Corp.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Hester Biosciences
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Phibro Animal Health
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Ceva Sante Animale
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Vetoquinol S.A.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Dechra Pharmaceuticals PLC
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
